16 September 2016 - The CADTH Drug Portfolio Information Sessions are an opportunity for stakeholders to receive an update on the agency's drug portfolio, including CADTH’s Common Drug Review, pan-Canadian Oncology Drug Review and Therapeutic Reviews.

CADTH will also provide updates on other CADTH programs such as patient engagement.

The sessions will be presented in English and can be attended in person or by webinar. Registration closes October 20, 2016.

Suggest agenda topic